维生素D与辅助生殖治疗结局:系统综述与Meta分析
该系统综述与Meta分析纳入11项队列研究共2700名接受辅助生殖技术(ART)的女性,评估血清维生素D与ART结局的关联。维生素D充足者活产(OR 1.33)、阳性妊娠试验(OR 1.34)和临床妊娠(OR 1.46)均更可能,流产无关联(OR 1.12)。
要点
- 维生素D充足女性ART活产可能性高于缺乏或不足者(OR 1.33)。
- 维生素D充足者阳性妊娠试验和临床妊娠可能性更高。
- 维生素D浓度与流产无显著关联(OR 1.12)。
核心结论
- 维生素D状态与接受ART女性的生殖治疗结局存在关联。
- 作者认为维生素D缺乏和不足可能是考虑ART女性需要治疗的重要状况。
- 作者建议考虑开展随机对照试验来验证治疗维生素D缺乏的获益。
研究设计与样本
- 系统综述与Meta分析,纳入11项已发表的队列研究,共2700名女性,检索MEDLINE、EMBASE、Cochrane Central Register of Controlled Trials和CINAHL。
主要发现
- 7项研究报告活产(含2026名患者),维生素D充足者活产可能性高于缺乏或不足者(OR 1.33 [1.08-1.65])。
- 5项研究(含1700名患者)报告阳性妊娠试验,维生素D充足者可能性高于缺乏或不足者(OR 1.34 [1.04-1.73])。
- 全部11项研究(含2700名患者)报告临床妊娠,维生素D充足者可能性更高(OR 1.46 [1.05-2.02])。
- 6项研究(含1635名患者)报告流产,维生素D浓度与流产无关联(OR 1.12 [0.81-1.54])。
- 纳入研究在Newcastle-Ottawa质量评估量表上得分良好。
临床怎么用
- 作者认为维生素D缺乏和不足可能是考虑ART女性需要治疗的重要状况。
- 作者建议考虑开展随机对照试验来验证治疗维生素D缺乏的获益。
局限性
- 尽管系统综述采用了严格的纳入标准,但纳入研究在人群特征和生育治疗方案方面存在异质性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is serum vitamin D associated with live birth rates in women undergoing ART? SUMMARY ANSWER: Women undergoing ART who are replete in vitamin D have a higher live birth rate than women who are vitamin D deficient or insufficient. WHAT IS KNOWN ALREADY: Vitamin D deficiency has been associated with an increased risk of abnormal pregnancy implantation as well as obstetric complications such as pre-eclampsia and fetal growth restriction. However, the effect of vitamin D on conception and early pregnancy outcomes in couples undergoing ART is poorly understood. STUDY DESIGN, SIZE, DURATION: A systematic review and meta-analysis of 11 published cohort studies (including 2700 women) investigating the association between vitamin D and ART outcomes. PARTICIPANTS/MATERIALS, SETTINGS, METHODS: Literature searches were conducted to retrieve studies which reported on the association between vitamin D and ART outcomes. Databases searched included MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials and CINAHL. Eleven studies matched the inclusion criteria. MAIN RESULTS AND THE ROLE OF CHANCE: Live birth was reported in seven of the included studies (including 2026 patients). Live birth was found to be more likely in women replete in vitamin D when compared to women with deficient or insufficient vitamin D status (OR 1.33 [1.08-1.65]). Five studies (including 1700 patients) found that women replete in vitamin D were more likely to achieve a positive pregnancy test than women deficient or insufficient in vitamin D (OR 1.34 ([1.04-1.73]). All 11 of the included studies (including 2700 patients) reported clinical pregnancy as an outcome. Clinical pregnancy was found to be more likely in women replete in vitamin D (OR 1.46 [1.05-2.02]). Six studies (including 1635 patients) reported miscarriage by vitamin D concentrations. There was no association found between miscarriage and vitamin D concentrations (OR 1.12 [0.81-1.54]. The included studies scored well on the Newcastle-Ottawa quality assessment scale. LIMITATIONS REASONS FOR CAUTION: Although strict inclusion criteria were used in the conduct of the systematic review, the included studies are heterogeneous in population characteristics and fertility treatment protocols. WIDER IMPLICATIONS OF THE FINDINGS: The findings of this systematic review show that there is an association between vitamin D status and reproductive treatment outcomes achieved in women undergoing ART. Our results show that vitamin D deficiency and insufficiency could be important conditions to treat in women considering ARTs. A randomized controlled trial to investigate the benefits of vitamin D deficiency treatment should be considered to test this hypothesis. STUDY FUNDING/COMPETING INTERESTS: No external funding was either sought or obtained for this study. The authors have no competing interests to declare. REGISTRATION NUMBER: N/A.
引用
- Chu J, Gallos I, Tobias A, et al. Vitamin D and assisted reproductive treatment outcome: a systematic review and meta-analysis. Hum Reprod. 2018. PMID: 29149263. doi:10.1093/humrep/dex326
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。